keyword
https://read.qxmd.com/read/38630117/erratum-overexpressed-eif3i-interacted-and-activated-oncogenic-akt1-is-a-theranostic-target-in-human-hepatocellular-carcinoma
#1
JOURNAL ARTICLE
(no author information available yet)
No abstract text is available yet for this article.
May 1, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38628351/a-novel-nir-ii-fl-pa-imaging-guided-synergistic-photothermal-immune-therapy-biomineralizing-nanosystems-integrated-with-anti-tumor-and-bone-repair
#2
JOURNAL ARTICLE
Xin Zhang, Dongsheng Li, Wenxuan Wang, Xiaochun Zheng, Chongqing Zhang, Yarong Jin, Shichao Meng, Jinxuan Li, Rong Dai, Weiwei Kang, Hua Wu, Ziliang Zheng, Ruiping Zhang
Advanced stages of breast cancer are frequently complicated by bone metastases, which cause significant cancer-related bone destruction and mortality. However, the early precise theranostics of bone metastasis remains a formidable challenge in clinical practice. Herein,a novel all-in-one nanotheranostic system (ABI NYs) combining NIR-II FL/PA dual-modal imaging with photothermal-immunity therapeutic functionalities in one component was designed to precisely localize bone metastasis microscopic lesions and achieve complete tumor ablation at an early stage...
June 2024: Materials today. Bio
https://read.qxmd.com/read/38627732/significance-of-psca-as-a-novel-prognostic-marker-and-therapeutic-target-for-cancer
#3
REVIEW
Tina Nayerpour Dizaj, Abolfazl Doustmihan, Behnaz Sadeghzadeh Oskouei, Morteza Akbari, Mehdi Jaymand, MirAhmad Mazloomi, Rana Jahanban-Esfahlan
One of the contributing factors in the diagnosis and treatment of most cancers is the identification of their surface antigens. Cancer tissues or cells have their specific antigens. Some antigens that are present in many cancers elicit different functions. One of these antigens is the prostate stem cell antigen (PSCA) antigen, which was first identified in the prostate. PSCA is a cell surface protein that has different functions in different tissues. It can play an inhibitory role in cell proliferation as well as a tumor-inducing role...
April 16, 2024: Cancer Cell International
https://read.qxmd.com/read/38625402/cadherin-17-as-a-target-for-the-immunopet-of-adenocarcinoma
#4
JOURNAL ARTICLE
Samantha Delaney, Outi Keinänen, Dennis Lam, Andrew L Wolfe, Takao Hamakubo, Brian M Zeglis
PURPOSE: Cadherin-17 (CDH17) is a calcium-dependent cell adhesion protein that is overexpressed in several adenocarcinomas, including gastric, colorectal, and pancreatic adenocarcinoma. High levels of CDH17 have been linked to metastatic disease and poor prognoses in patients with these malignancies, fueling interest in the protein as a target for diagnostics and therapeutics. Herein, we report the synthesis, in vitro validation, and in vivo evaluation of a CDH17-targeted 89 Zr-labeled immunoPET probe...
April 16, 2024: European Journal of Nuclear Medicine and Molecular Imaging
https://read.qxmd.com/read/38622800/novel-cutting-edge-nano-strategies-to-address-old-long-standing-complications-in-cardiovascular-diseases-a-comprehensive-review
#5
REVIEW
Laura Tesoro, Ignacio Hernandez, Marta Saura, Lina Badimón, Carlos Zaragoza
BACKGROUND: Cardiovascular diseases (CVD) impact a substantial portion of the global population and represent a significant threat to experiencing life-threatening outcomes, such as atherosclerosis, myocardial infarction, stroke and heart failure. Despite remarkable progress in pharmacology and medical interventions, CVD persists as a major public health concern, and now ranks as the primary global cause of death and the highest consumer of global budgets. Ongoing research endeavours persist in seeking novel therapeutic avenues and interventions to deepen our understanding of CVD, enhance prevention measures, and refine treatment strategies...
April 15, 2024: European Journal of Clinical Investigation
https://read.qxmd.com/read/38621754/multicomponent-dnazyme-nanomachines-structure-applications-and-prospects
#6
REVIEW
Daria D Nedorezova, Maria S Rubel, Aleksandr A Rubel
Nucleic acids (NAs) are important components of living organisms responsible for the storage and transmission of hereditary information. They form complex structures that can self-assemble and bind to various biological molecules. DNAzymes are NAs capable of performing simple chemical reactions, which makes them potentially useful elements for creating DNA nanomachines with required functions. This review focuses on multicomponent DNA-based nanomachines, in particular on DNAzymes as their main functional elements, as well as on the structure of DNAzyme nanomachines and their application in the diagnostics and treatment of diseases...
January 2024: Biochemistry. Biokhimii︠a︡
https://read.qxmd.com/read/38619821/breaking-barriers-in-cancer-treatment-nanobiohybrids-empowered-by-modified-bacteria-and-vesicles
#7
REVIEW
Muhammad Ijaz, Mohsin Khurshid, Jingsi Gu, Ikram Hasan, Shubham Roy, Zia Ullah, Simin Liang, Jing Cheng, Yinghe Zhang, Chao Mi, Bing Guo
Cancer, the leading global cause of mortality, poses a formidable challenge for treatment. The effectiveness of cancer therapies, ranging from chemotherapy to immunotherapy, relies on the precise delivery of therapeutic agents to tumor tissues. Nanobiohybrids, resulting from the fusion of bacteria with nanomaterials, constitute a promising delivery system. Nanobiohybrids offer several advantages, including the ability to target tumors, genetic engineering capabilities, programmed product creation, and the potential for multimodal treatment...
April 15, 2024: Nanoscale
https://read.qxmd.com/read/38616166/porphysome-engineered-with-specific-protein-binding-sites-as-a-multimodal-theranostic-nanocarrier-for-targeted-protein-delivery
#8
JOURNAL ARTICLE
Niloofar Ayyari, Zahra Vaezi, Zeinab Fotouhi Ashin, Elham Karimi, Fatemeh Mohsenzadeh Haji, Maryam Nikkhah, Hossein Naderi-Manesh
The immobilization of proteins on the surface of carriers is challenging due to the loss of protein structure and function in this process. Here, we report the development of the protein immobilization on the surface of the metallated-porphyrin complex in the porphysome nanocarrier. The conjugated Ni-porphyrin to fatty acid (as a tail) has been synthesized and independently placed at the depth of the bilayer center of Dipalmitoylphosphatidylcholine (DPPC) in which the Ni-porphyrin was at the polar region of the membrane and is thus superficial...
April 14, 2024: Chemistry & Biodiversity
https://read.qxmd.com/read/38616095/a-chitosan-camouflaged-nanomedicine-triggered-by-hierarchically-stimuli-to-release-drug-for-multimodal-imaging-guided-chemotherapy-of-breast-cancer
#9
JOURNAL ARTICLE
Pei Wang, Zhi Peng, Yanyan Zhang, Xuejing Zhang, Xia Chen, Fan Li, Bo Chen, Shiwei Niu, Kaili Du, Li-Min Zhu
Breast cancer remains one of the most intractable diseases, especially the malignant form of metastasis, with which the cancer cells are hard to track and eliminate. Herein, the common known carbohydrate polymer chitosan (CS) was innovatively used as a shelter for the potent tumor-killing agent. The designed nanoparticles (NPs) not only enhance the solubility of hydrophobic paclitaxel (PTX), but also provide a "hide" effect for cytotoxic PTX in physiological condition. Moreover, coupled with the photothermal (PTT) properties of MoS2 , results in a potent chemo/PTT platform...
July 1, 2024: Carbohydrate Polymers
https://read.qxmd.com/read/38611074/leveraging-programmatic-collaboration-for-a-radiopharmaceutical-clinic
#10
JOURNAL ARTICLE
Charles A Kunos, Molly E Martin, Michalis F Georgiou, Russ A Kuker, Aman Chauhan
Radiation oncologists, radiopharmacists, nuclear medicine physicians, and medical oncologists have seen a renewed clinical interest in radiopharmaceuticals for the curative or the palliative treatment of cancer. To allow for the discovery and the clinical advancement of targeted radiopharmaceuticals, these stakeholders have reformed their trial efforts and remodeled their facilities to accommodate the obligations of a program centered upon radioactive investigational drug products. Now considered informally as drugs and not beam radiotherapy, radiopharmaceuticals can be more easily studied in the traditional clinical trial enterprise ranging from phase 0-I to phase III studies...
April 2, 2024: Cancers
https://read.qxmd.com/read/38610749/pre-treatment-and-post-treatment-i-131-imaging-in-differentiated-thyroid-carcinoma
#11
REVIEW
Jasna Mihailović
Radioiodine imaging in initial perioperative settings, after the total thyroidectomy, includes pre-treatment and post-treatment radioiodine imaging. While the benefit of post-treatment whole-body imaging (PT-WBI) is well established, the role of diagnostic whole-body imaging (dx WBI), prior to radioiodine (I-131) ablative or therapeutic doses, is controversial. Dx WBI has been abandoned in most nuclear medicine centers long ago. Planar low-dose dxWBI provides the volume of postoperative thyroid remnants, but it cannot detect occult metastatic foci in the neck...
March 29, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38609263/dual-biomarkers-activatable-hollow-mno-2-based-theranostic-nanoplatform-for-efficient-breast-cancer-specific-multisite-fluorescence-imaging-and-synergistic-therapy
#12
JOURNAL ARTICLE
Juan Ning, Guizhen Hu, Tian Wu, Yijun Zhao, Yamin Nie, Yanmei Zhou
BACKGROUND: Theranostic nanoplatforms with integrated diagnostic imaging and multiple therapeutic functions play a vital role in precise diagnosis and efficient treatment for breast cancer, but unfortunately, these nanoplatforms are usually stuck in single-site imaging and single mode of treatment, causing unsatisfactory diagnostic and therapeutic efficiency. Herein, a dual biomarkers-activatable facile hollow mesoporous MnO2 (H-MnO2 )-based theranostic nanoplatform, DNAzyme@H-MnO2 -MUC1 aptamer (DHMM), was constructed for the simultaneous multi-site diagnosis and multiple treatment of breast cancer...
May 15, 2024: Analytica Chimica Acta
https://read.qxmd.com/read/38608464/quercetin-derived-red-emission-carbon-dots-a-multifunctional-theranostic-nano-agent-against-alzheimer-s-%C3%AE-amyloid-fibrillogenesis
#13
JOURNAL ARTICLE
Zitong Wei, Xiaoyan Dong, Yan Sun
Multifunctional agents with therapeutic and diagnostic capabilities are imperative to the prevention of Alzheimer's disease (AD), which is considered due to abnormal aggregation and deposition of β-amyloid protein (Aβ) as well as oxidative stress. Herein, quercetin (Que)- and p-phenylenediamine (p-PD)-derived red emission carbon dots (CDs) synthesized via a one-step hydrothermal method were designed as a novel theranostic nano-agent for the multi-target treatment of AD. R-CD-75 with an optimized composition exhibited significant inhibition of Aβ aggregation and rapid depolymerization of mature Aβ fibrils (<4 h) at micromolar concentrations (2 and 5 μg/mL, respectively)...
April 9, 2024: Colloids and Surfaces. B, Biointerfaces
https://read.qxmd.com/read/38607326/macrophage-membrane-camouflaged-nanoclusters-of-ultrasmall-iron-oxide-nanoparticles-for-precision-glioma-theranostics
#14
JOURNAL ARTICLE
Bin Zhang, Rui Yang, Hongwei Yu, Yamin Peng, Haoyu Huang, Meera Moydeen Abdul Hameed, Han Wang, Guixiang Zhang, Mohamed El-Newehy, Mingwu Shen, Xiangyang Shi, Shaojun Peng
Developing effective nanomedicines to cross the blood-brain barrier (BBB) for efficient glioma theranostics is still considered to be a challenging task. Here, we describe the development of macrophage membrane (MM)-coated nanoclusters (NCs) of ultrasmall iron oxide nanoparticles (USIO NPs) with dual pH- and reactive oxygen species (ROS)-responsivenesses for magnetic resonance (MR) imaging and chemotherapy/chemodynamic therapy (CDT) of orthotopic glioma. Surface citrate-stabilized USIO NPs were solvothermally synthesized, sequentially modified with ethylenediamine and phenylboronic acid, and cross-linked with gossypol to form gossypol-USIO NCs (G-USIO NCs), which were further coated with MMs...
April 12, 2024: Biomaterials Science
https://read.qxmd.com/read/38606663/synthesis-screening-and-evaluation-of-theranostic-molecular-cpcr4-based-probe-targeting-cxcr4
#15
JOURNAL ARTICLE
Tingting Yang, Dai Shi, Qingyu Lin, Hua Shen, Hui Tan, Yuxia Liu, Hongcheng Shi, Dengfeng Cheng
Chemokines and chemokine receptors are indispensable to play a key role in the development of malignant tumors. As one of the most widely expressed chemokine receptors, chemokine (C-X-C motif) receptor 4 (CXCR4) has been a popular research focus. In most tumors, CXCR4 expression is significantly upregulated. Moreover, integrated nuclide diagnosis and therapy targeting CXCR4 show great potential. [68 Ga]Ga-pentixafor, a radioligand targeting CXCR4, exhibits a strong affinity for CXCR4 both in vivo and in vitro...
April 12, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38606282/post-synthesis-oxidation-of-superparamagnetic-iron-oxide-nanoparticles-to-enhance-magnetic-particle-imaging-performance
#16
JOURNAL ARTICLE
Ambar C Velazquez-Albino, Aniela Nozka, Andrii Melnyk, Hayden J Good, Carlos M Rinaldi-Ramos
This study investigates the impact of post-synthesis oxidation on the performance of superparamagnetic iron oxide nanoparticles (SPIONs) in magnetic particle imaging (MPI), an emerging technology with applications in diagnostic imaging and theranostics. SPIONs synthesized from iron oleate were subjected to a post-synthesis oxidation treatment with a 1% Oxygen in Argon mixture. MPI performance, gauged via signal intensity and resolution using a MOMENTUM™ scanner, was correlated to the nanoparticles' physical and magnetic properties...
January 12, 2024: ACS Applied Nano Materials
https://read.qxmd.com/read/38604761/clinical-management-of-advanced-prostate-cancer-where-does-radiopharmaceutical-therapy-fit-in-the-treatment-algorithm
#17
JOURNAL ARTICLE
Paul Viscuse, Michael Devitt, Robert Dreicer
Most men with newly appreciated metastatic prostate cancer are optimally treated with a backbone consisting of androgen receptor-directed therapy with or without taxane chemotherapy. Despite improvements in disease outcomes, prostate cancer remains an extremely heterogeneous disease with variable mechanisms of therapeutic resistance. As a result, it remains a leading cause of cancer-related death in men. Radiopharmaceutical therapy has emerged as an alternative, non-androgen receptor-directed treatment modality for metastatic castration-resistant prostate cancer that impacts patient survival and represents a potentially more personalized approach...
April 11, 2024: Journal of Nuclear Medicine
https://read.qxmd.com/read/38604287/precision-nanomedicine-to-treat-non-small-cell-lung-cancer
#18
REVIEW
Akanksha Dessai, Usha Yogendra Nayak, Yogendra Nayak
Lung cancer is a major cause of death worldwide, being often detected at a later stage due to the non-appearance of early symptoms. Therefore, specificity of the treatment is of utmost importance for its effective treatment. Precision medicine is a personalized therapy based on the genomics of the patient to design a suitable drug approach. Genetic mutations render the tumor resistant to specific mutations and the therapy is in vain even though correct medications are prescribed. Therefore, Precision medicine needs to be explored for the treatment of Non-small cell lung cancer (NSCLC)...
April 9, 2024: Life Sciences
https://read.qxmd.com/read/38603864/direct-radiolabeling-of-methotrexate-and-methotrexate-micelles-with-tc-99m-using-qbd-approach
#19
JOURNAL ARTICLE
Prashant G Upadhaya, Swapna J Nabar
The aim of the work presented in this manuscript was to radiolabel methotrexate and prepare radiolabeled methotrexate micelles, an antifolate drug with Tc-99m using QbD approach. The radiolabeling was executed using the experimental design and the radiolabeled drug was further encapsulated in micelles. The authors are of the view that the radiolabeled MTX could be used to target the folate receptor overexpressing cancers such as the kidney, colorectal, breast, brain etc thereby opening newer possibilities to the theranostic applications of the formed conjugate...
April 7, 2024: Applied Radiation and Isotopes
https://read.qxmd.com/read/38603827/biomimetic-and-multifunctional-nanocomposites-for-precision-fungi-theranostics
#20
JOURNAL ARTICLE
Li Wang, Yueyue Gui, Kexin Li, Wei Tao, Chao Li, Jin Qiu, Jiehua Ma
Fungi infection is a serious threat to public health, but an effective antifungal strategy remains a challenge. Herein, a biomimetic nanocomposite with multifunctionalities, including fungi diagnosis, antifungal adhesion, precise fungi elimination, and cytokine sequestration, is constructed for battling Candida albicans (C. albicans) infection. By screening a range of cells, we find that the polarized macrophage cells have the strongest binding tendency toward C. albicans. Thus, their membranes were exfoliated to camouflage UCNPs and then decorated with photosensitizers (methylene blue, MB) and DNA sensing elements...
April 4, 2024: Biomaterials
keyword
keyword
55531
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.